Search

Filters
Clear All
  • 14
  • 49
  • 623

Phase

  • 12
  • 15
  • 54
  • 8
  • 71
  • 4
  • 513
  • 607
  • 281
  • 673
  • 13

Found 686 in-health trials

A listing of in-health medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

M
Monika Fischer, MD
18 years - 75 years
All genders
Phase 3
Interventional
This study investigates the use of an investigational medication for people with moderately to severely active Crohn's disease, a condition that causes inflammation in the digestive tract. The investigational medication is a type of antibody that targets a protein involved in the immune response in the gut. The study aims …
S
Sandeep Batra, MD
15 years - 20 years
All genders
This study investigates a home-based physical activity program designed for Hispanic or Latino/Latina adolescent and young adult (AYA) childhood cancer survivors. After cancer treatment, some AYA survivors may experience long-term effects like weight gain, tiredness, and reduced fitness. Hispanic or Latino/Latina survivors might face a higher risk of these effects. …
M
Marian Pfefferkorn
3 years or above
All genders
Phase 3
Interventional
This study investigates the long-term safety of an investigational medication in children with conditions like Crohn's disease, ulcerative colitis, or juvenile psoriatic arthritis. Crohn's disease and ulcerative colitis are types of inflammatory bowel diseases that cause inflammation in the digestive tract, while juvenile psoriatic arthritis is a type of arthritis …
J
Jennifer King
18 years - 100 years
All genders
This study investigates the effects of adding an investigational medication to a standard treatment for patients with high-risk renal cell carcinoma (RCC). RCC is a type of kidney cancer. The purpose of this study is to see if the investigational medication, when combined with the standard treatment, works better than …
M
Myda Khalid
10 years or above
All genders
Phase 2
Interventional
This study investigates the safety and effects of an investigational medication in people with autoimmune kidney diseases. These conditions include IgA Nephropathy (IgAN), Primary Membranous Nephropathy (pMN), and Minimal Change Disease/Focal Segmental Glomerulosclerosis (MCD/FSGS). Autoimmune kidney diseases occur when the body's defense system attacks the kidneys, causing damage. This study …
N
Nicole Fowler
65 years - 100 years
Accepts healthy volunteer
All genders
This study investigates the use of a Passive Digital Marker (PDM) to identify people at risk of Mild Cognitive Impairment (MCI) and Alzheimer's Disease and Related Dementias (ADRD). The PDM is a tool that uses electronic medical records to find patients who might be at risk. Patients identified by the …
S
Sandeep Batra, MD
366 days - 42 years
All genders
Phase 3
This study investigates treatments for a type of blood cancer called Philadelphia chromosome-positive or ABL-class Philadelphia chromosome-like B-cell acute lymphoblastic leukemia (B-ALL). B-ALL is a cancer of the white blood cells. The study looks at the effects of combining blinatumomab, a special antibody that helps the immune system fight cancer, …
E
Eric Orman
18 years - 100 years
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication on hereditary hemochromatosis, a condition where the body absorbs too much iron from food, leading to excess iron storage in organs. The purpose of this study is to evaluate how the investigational medication affects liver iron concentration (LIC) in adults with …
T
Tarah Ballinger, MD
18 years - 100 years
Female
This study investigates how genetic ancestry affects the completion of treatment in patients diagnosed with breast cancer. Breast cancer is a disease where cells in the breast grow out of control. This study involves newly diagnosed women with stages I-III breast cancer who self-report as Black or White.Participants will provide …
A
Anthony Ross
180 days - 22 years
All genders
Phase 2
Interventional
This study investigates an investigational medication for treating Langerhans cell histiocytosis (LCH), a disease where the body makes too many immature Langerhans cells, a type of white blood cell. These cells can build up and form tumors in organs like bones, skin, and lungs, causing damage. The purpose of the …
501 - 510 of 686